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From a review of work by many investigators on a variety of virus infections 
Rivers  (1)  concludes  that immune serum as a  therapeutic agent is valueless 
in most instances if it is given after the onset of signs of disease.  His view is 
that when signs and symptoms of a  malady become obvious, the viruses of a 
number  of diseases "have already  reached  practically all  the  cells  that  are 
likely to be attacked;" the virus then is not reached by antibody so long as 
the infected cell lives (cf. Rous and Jones, (2)) and hence antiserum is not help- 
ful.  An exception to this view has recently been taken by Zichis and Shaugh- 
nessy (3) who reported successful treatment of experimental infection of mice 
and guinea pigs with the Western equine encephalomyelitis virus by means of 
hyperimmune rabbit serum administered at onset of symptoms. 
Zichis and Shaughnessy emphasized that their positive results were obtained when 
large amounts of highly potent serum were injected.  The potency required of an 
antiserum  was  that  1  cc.  of a  1:1000  dilution  introduced  subcutaneously  should 
protect mice against  10 ~.L.D. of virus given intracerebrally 24 hours later.  Anti- 
serum of this minimal standard  could be produced in rabbits after a  course of at 
least thirty-six inoculations of active virus given over a period of 12 weeks.  Single 
or multiple doses of 1 or 2 cc. sufficed for the treatment of mice, of 5 or 10 cc. for 
guinea pigs; the Iargest total amount inoculated into a single 400 gm. guinea pig was 
recorded as 70 cc. 
Howitt (3 a) had reported an earlier attempt at experimental serotheraphy in 
guinea pigs infected with Western virus.  The serum was effective when it was 
administered at the 4th hour  but  ineffective at  the  10th  hour after an intra- 
cerebral  injection  of  virus.  If  the  latter  was  given  by  the  nasal route  the 
disease could be prevented by the serum to the 48th hour after virus instillation. 
* This investigation was made in  collaboration with the  Commission on Neuro- 
tropic  Virus  Diseases,  Board  for  the  Investigation and  Control  of Influenza and 
Other Epidemic Diseases in the Army. 
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Wyckoff and Tesar (4)  described an attempt to treat Eastern and Western 
virus infections of monkeys with hyperimmune horse serum. 
No animal survived when serum was administered at the first sign (fever) or later. 
When it was given early, 3 to 24 hours after nasal instillation of virus, three of six 
monkeys survived.  The  survivors, as well  as  three  control  monkeys which  had 
received the serum alone, were susceptible to infection by the same route  7 weeks 
later.  This indicated (4) that no active immunity was induced. 
The  emphasis placed by Zichis  and  Shaughnessy  on  the  quantitative  re- 
quirements in effective serotherapy evoked our interest.  Previous studies in 
our laboratory had revealed in actively immunized mice a  quantitative rela- 
tionship between serum antibody titer and the degree of resistance to intra- 
cerebral (5) and to peripheral (6) injection of the active equine virus.  It was 
shown later  (7)  that rabbits actively immunized to such a  degree that a~ti- 
body could be demonstrated in the cerebrospinal fluid or brain tissue resisted 
an intracerebral test inoculation.  The presence of antibody in the spinal fluid 
was interpreted as an indicator of the availability of antibody to the tissues 
directly exposed to the virus after intracerebral inoculation. 
On this basis the results published by Zichis and Shaughnessy suggested two 
lines of investigation:  (a) whether the effectiveness of antiserum in the preven- 
tion and treatment of the experimental disease depended on quantitative rela- 
tions  similar  to  those  established  in active immunization;  (b)  whether sero- 
therapy, even if it met such requirements, could arrest the course of the infec- 
tion after onset of signs. 
Methods and Materials 
Virus.--Two  strains of Western equine  encephalomyelitis virus were employed, 
one propagated in this laboratory for 9 years, hereafter designated as the Rockefeller 
Institute strain, and one which was kindly sent to us by Dr. Joseph Zichis.  They 
are serologically  identical but infection with the Zichis virus is  characterized by a 
longer  incubation period.  Unless  otherwise stated  the Rockefeller  Institute strain 
was used. 
Animals.--Swiss and Rockefeller Institute  strains of mice were employed; they 
were equally susceptible to the virus and equally protected by any given immune 
serum.  Young adult mice, about 1 month old,  were used except for neutralization 
tests by the intraperitoneal method, when 11- to 13-day-old animals were substituted. 
Rabbits for immunization weighed  approximately 3000 gin.,  and albino and  mixed 
"breeds  of guinea pigs from 170 to 400 gin.  Further details concerning the handling 
of animals have been described  (6,'7). 
Immune Sera.--The rabbit antisera have been designated according to the number 
and the type of injections given; for example, 46 W represents forty-six injections of 
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tions of active Western virus  (Rockefeller Institute strain)  is described in the fol- 
lowing outline:-- 
Type of 
antisera 
1W 
3W 
46 W 
48 W 
Virus used for 
immunization 
20 per cent chick em- 
bryo in saline solu- 
tion 
Mouse brain, 
then 
20 per cent chick em- 
bryo in saline solu- 
tion 
Same as 46 W, 
then 
20 per cent chick 
embryo 
No. of 
injec- 
tions 
38 
46 
2 
Dose 
2  CC. 
2, 4, 5 cc. 
1 to 3 mouse brains, each 
dose in 5 cc. broth 
0.5, 1, 2, 4, 5, 5, 5 co. 
Same as 46 W 
5 cc., 5 co. 
Route 
Subcutane- 
ous 
Intravenous 
Interval 
between 
injections 
Weekly 
cc 
3X 
weekly 
The Z W serum was kindly sent us by Dr. Zichis at our request for a sample of his 
potent  hyperimmune  rabbit  serum.  According to  his  records,  its  titer  in  mouse 
protection tests was 1:500 against 100 ~.L.D. of virus but in a previous titration had 
been 1 : 1000 against 5 to 10 ~.L.D.  Moreover, he reported that this serum had been 
used for the treatment of infected guinea pigs with a recovery rate of 60 per cent. 
Tests.--Neutralization  tests were  carried  out  in  mice  by  the  intracerebral  (5)  1 
or by the intraperitoneal (8) method.  Protection tests followed closely the methods 
of Zichis and Shaughnessy (3) : intracerebral injection of active virus 24 hours after 
subcutaneous inoculation of immune serum.  Therapeutic tests were those in which 
serum was given after the virus regardless of the time of onset of signs.  The tech- 
nique for each test is described in the text. 
Tests for Potency of Antisera 
The potency of the various antisera was measured by (a) protection tests; 
(b)  tests for the capacity of sera obtained from passively immunized mice to 
neutralize the virus; and (c) neutralization tests by the intraperitoneal and by 
the intracerebral methods.  The purpose of these tests was to find out whether 
at least thirty-six injections of active virus (3) were required to produce a rabbit 
hyperimmune serum of the standard potency. 
Protection Tests.--Protection tests were done in order to compare the capac- 
ity of various antisera  to protect mice against subsequent intracerebral injec- 
tion of active virus. 
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1 cc. of undiluted or diluted serum was injected subcutaneously into mice and 24 
hours later virus was inoculated intracerebrally.  The virus used in these tests was 
guinea pig brain and the lethal end-point of  both the Zichis and the  Rockefeller 
Institute strains of virus in this form was 10 -5 to 10 -6  . 
A summary of the results obtained is given: In one test undiluted 3 W and 46 W 
antisera both protected mice against the largest measurable amount of virus, Insti- 
tute strain, i.e.,  10,000 cerebral ~a.L.D. 
In a number of tests employing the Institute strain, no protection against 10 M.L.D. 
occurred with a 1 : 1000 dilution of the 46 W antiserum.  The Z W antiserum, diluted 
1:100,  had little or  no protective capacity.  In 1:500 dilution it was  ineffective. 
On the other hand, when the Zichis strain of virus was used, both the 3 W and the 
TABLE I 
Neutralizing Capacity of Sera of Mice 24 Hours after Passive Immunization 
Rabbit antiserum used for  Dilution of mouse serum tested 
immunization (1 cc. subcutaneously)  with 10  -s Western virus* 
Type  Dilution  1:100  1:300 
46 W 
3W 
Undiluted 
1:100 
1:1000 
Undiluted 
1:100 
1:1000 
0/4~ 
3/4 
3/4 
o/4 
1/4 
1/4 
2/4 
3/4 
4/4 
0/4 
3/4 
4/4 
* Control mice injected with normal rabbit serum and Rockefeller Institute virus: 10  4, 
5/6; 10  -9  , 2/6. 
:~ Number of mice dead/number  injected intracerebrally. 
46 W sera in dilutions of 1 : 100 and 1 : 1000 protected mice against at least 10 cerebral 
~.L.D.  The Z W  antiserum was not tested with the Zichis strain of virus because 
more of the serum was not available. 
Neutralizing Capacity of Sera  of Passively Immunized  Mice.--The  purpose 
of the tests shown in Table I  was to compare the antibody titers in sera of mice 
passively immunized with undiluted or diluted 46 W  or 3 W  autisera just be- 
fore the mice were exposed to an intracerebral test dose of the Zichis virus. 
The mice were bled 24 hours after the injection of antiserum; the mouse sera were 
pooled according to type and dilution of antiserum received.  Each pool was then 
diluted 1:100 and 1:1000 and these dilutions were tested for capacity to neutralize 
virus by intracerebral test in mice, as tabulated. 
The results failed to indicate that  the injection of  46 W  antiserum produced a 
higher antibody level than that of 3 W antiserum. 
Neutralization Tests.--In the following experiments the neutralizing capaci- 
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1. Intraperitoneal Method.--In the neutralization test by this method the different 
sera were diluted  1:300.  At this dilution 46 W  serum neutralized  1000 peritoneal 
lethal doses of virus  (on repetition,  1000+  doses); 3 W, between  100 and  1000 (on 
repetition,  1000+), and 1 W, 10 to 100 doses. 
No difference could be detected by the intraperitoneal  neutralization test in mice 
between 46 W  and 3 W  antisera. 
2. IntracerebraI Mahod.--Finally,  by means  of intracerebral  neutralization  tests 
in  mice,  complete  titrations  of the  neutralizing  capacity  of serum  dilutions  were 
carried out.  Antisera 46 W and 3 W were found to be equivalent in theirneutralizing 
capacity over the entire range of serum dilutions; that of 1 W serum was, however, at 
a lower level.  Results obtained in this way will be discussed later (Morgan, 9). 
Comment.--The  high  degree  of protection  induced  in  mice  by  antiserum 
against  infection  with  the  virus  was noteworthy.  1  cc.  of undiluted  serum 
given  subcutaneously 24 hours  before virus was introduced  directly into  the 
brain  protected  the  animal  against  as much as  10,000  mouse  cerebral  lethal 
doses of virus.  When diluted 1:1000, as Zichis and Shaughnessy have already 
noted (3), it still protected against about 10 lethal doses of one strain of Western 
virus given intracerebrally. 
Mice resisted an intracerebral test inoculation of active virus at a  time when the 
sera of certain ones had a  neutralizing  titer of only 1:100 or less  (cf. Table I).  It 
was found previously (7) in actively immunized rabbits that the ratio between serum 
antibody and antibody in the cerebrospinal fluid was 300:1.  The minimal titer at 
which such rabbits resisted an intracerebral inoculation of 10 to 1000 rabbit cerebral 
lethal  doses  was  1:200.  This  relationship  cannot,  however,  be  compared directly 
with  that  found in passively immunized mice since:  (a)  The mice were passively, 
the  rabbits  actively  immunized.  (b)  The  mice  resisted  10  mouse  cerebral  lethal 
doses of the Zichis strain:  mice of another series,  similarly treated,  were fully sus- 
ceptible to 10 such doses of the Rockefeller Institute virus, which had beenemployed 
in the rabbit experiments  (7).  (c)  Approximately 1000 times less  virus in terms of 
mouse cerebral lethal doses was injected into mice than into rabbits,  and therefore 
less antibody would be required for its neutralization.  (d)  Intracerebral inoculation 
in mice causes hemorrhage and consequently virus is exposed to neutralizing action 
of the blood. 
The foregoing tests show that it is not necessary to give a  large number of 
injections of active virus to rabbits in order to produce an antiserum of maxi- 
mal  potency.  Indeed,  antisera  equivalent  in  all  respects  were  obtained  by 
vaccination of rabbits with from three to as many as forty-eight doses of active 
virus (cf. references  10 and  11). 
Therapeutic  Use of Antisera 
Serotherapy  in Mice Injected with  Virus by the Intracerebral  Route.--Zichis 
and  Shaughnessy  (3)  stated  that  serotherapy was successful  when antiserum 
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virus.  More  than  one-half  the  number  survived  even  though  certain  ones 
showed  visible signs of  infection of  the  central  nervous  system  (prostration 
and partial paralysis) at the time of treatment. 
The  results of our  experiments on  serotherapy in  mice  after  intracerebral 
introduction  of  the  Rockefeller Institute  strain  of  virus  are  summarized  in 
Table II. 
TABLE II 
Effect of Serotherapy in Mice 
(1 cc. undiluted antiserum intraperitoneally into mice after intracerebral inoculation of 
guinea pig brain virus, Rockefeller Institute strain.) 
I 
Experi- l 
ment 
NO. 
Interval 
between 
virus and 
serum 
inoculation 
hrs. 
48* 
24 
24 
24 or 45 
24 
45 
24 
24 
45 
Type of serum 
injected 
None 
46W 
Normal rabbit 
46 W 
Normal rabbit 
46W 
3W 
Normal rabbit 
ZW 
ZW 
Normal rabbit 
ZW 
ZW 
Results 
10-',  10-4 
5/.'  6/6 
--  5/6 
--  5/6 
6/(  3/6 
--  6/6 
6/{  6/6 
6/t  s/6 
--  5/6 
6/6 
--  5/6 
104  i I0~' 
0/8  -- 
0/6  -- 
0/6  -- 
3/6  -- 
3/6  -- 
1/6  -- 
s/8  i/6 
2/6  -- 
5/6  -- 
1/6  0/6 
2/6  -- 
1/6  -- 
Therapeutic effect 
0 
10 M.L.D. 
0 
0 
10-100 xt.L.O. 
0 
< 10 mL.D.? 
0 
* At 45 hours most of the mice exhibited first signs:  ruffled fur, slowness, ataxia. 
It will be observed that when any of the different  sera was given 45  to 48 
hours after the virus, that is to say, at a  time when the first signs of the disease 
became apparent  (ruffled fur,  slowness, weakness,  unsteadiness,  and  ataxia), 
it  failed  to  prevent  death.  Moreover,  when  the  antisera  were  injected  24 
hours after the virus, at a  time when no signs were obvious, little or no effect 
was produced. 
The experiment was repeated with the Zichis strain of virus.  Mice were injected 
intracerebrally with 10 •.L.9.  of virus.  After 3 to 5 days, at the onset of signs, 2 cc. 
of either 48 W  or 3 W, or normal rabbit serum, were administered subcutaneously. 
In certain cases the dose was repeated  after 5½ to  48  hours.  In all, twenty-seven P.  K.  OLITSKY,  R.  W.  SCILLESINGER,  I.  M.  MORGAN  365 
mice received immune serum and thirteen normal serum.  All died, the control and 
test animals within the same period of time. 
Thus antiserum even in prodigious amounts given to mice at the first signs 
of encephalomyelitis induced by intracerebral inoculation of virus was without 
therapeutic  effect.  The intracerebral  method of inoculating virus, moreover, 
was believed to be too drastic; the host was overwhelmed at the start and  ap- 
praisal of a  serum under such circumstances would therefore be difficult. 
Serotherapy in Guinea Pigs Injected with Virus by the Intralingual Route.--It 
was reported (3) that guinea pigs were also successfully treated with antiserum 
given  intraperitoneally  (in  certain  instances  intracardially  or intravenously) 
after  the  onset  of fever  or  even  of encephalitic  signs. 
About two-thirds  the number of animals receiving such treatment  survived  (3). 
Indeed, certain of the survivors treated after onset of signs were resistant  to a later 
intracerebral injection of virus while those treated at an earlier stage were not.  This 
indicated to Zichis and Shaughnessy that infection had proceeded  far enough at the 
time serotherapy was begun to lead to active immunity. 
In the present  series,  twelve 250  to 350  gm.  guinea pigs received intralinguaUy 
0.3 cc. of  10  -2 dilution of virus  suspension (Zichis strain).  5 to 8 days later, at the 
first rise  of temperature,  10 cc. of antiserum were injected intraperitoneally into six 
(three of them received an additional 10 cc. from 24 to 48 hours after the first  dose) 
and  10 cc.  of normal rabbit serum were inoculated into the remaining six.  Two of 
the six in the control group died and four (including three which received a  second 
dose of immune serum) of the six in the treated group. 
There was no indication that serotherapy prevented death although the low 
incidence of mortality in the control group makes an appraisal difficult.  Fur- 
ther experiments are in progress. 2 
Serotherapy in Guinea  Pigs Injected  with  Virus  by the Plantar  Route.--At 
this point a  paper by Traub  (13)  became available,  in which he reported  the 
results of serum treatment in guinea pigs after pad inoculation of Eastern and 
Western virus.  The regularity with which young guinea pigs could be infected 
by this peripheral route suggested its use in the present  studies. 
Traub  (13)  inoculated horse or guinea pig Eastern  or Western  virus suspension 
(0.5 ce. of 10  -2 dilution) into the pads of guinea pigs.  An inoculation was followed 
by a  diphasic  febrile  course,  the afebrile  interphase  occurring about  the  2nd  day 
after injection (13, 14).  If serum was given intracardially 24 to 56 hours after Eastern 
virus, death was prevented, provided the second febrile  phase had not as yet begun. 
If serum was introduced 48 to 105 hours after injection of virus, during the second 
febrile phase, then it had no effect. 
2 As this paper is being written, a preliminary report by Davison and Fulton (12) 
has appeared in which it is stated that antiserum is of little value in the treatment 
of guinea  pigs  infected  by intracerebral  injection  of Western  virus; also  that  the 
results  of serotherapy of man having the active disease  were inconclusive. 366  RESISTANCE  TO  EQUINE  ENCEPHALOMYELITIS  VIRUS.  II 
The following two experiments were carried out to test the effect of antiserum 
administered at various intervals after plantar inoculation of active virus. 
The  Rockefeller Institute strain of  virus and  48  W  antiserum were  employed" 
The virus was in the form of 20 per cent chick-embryo suspension in broth, 0.125 cc. 
of which inoculated into each hind pad gave  rise to infection of 150 to 200 gm. guinea 
pigs in all instances and to  death in the  majority.  The serum was  administered 
intracardially and, when repeated, intraperitoneally in doses of 1 cc. 
TABLE III 
Serotherapy Following Pad Inoculation of Western Virus; One Dose (1 Cc.) of Serum Injected 
Intracardially 
Time of serum 
treatment 
Hrs. after virus 
inoculation 
No serum 
(controls) 
24 
48 
72 
96 
No. of I 
guinea  I 
pigs 
used  t 
8 
Signs at time serotherapy began 
Fever (104-105.2°F.) 
1, afebrile interphase 
3, fever (104-105.8°F.) 
2, 2nd febrile phase 
2,  "  "  "  + 
CNS signs 
2 died 4 d.  No serum given 
2 CNS signs; treated 
Results 
died  of virus  effect,  average  time 
about 4 d.;* 2 survived but showed 
4 and 5 d. febrile reactions 
died of virus effect 18 d.; 3 survived 
died of virus effect: 1, 4 d.; 1, 9 d.; 
1, 13 d.; 1, 24 d. 
died of virus effect and 1 survived 
with posterior limb paralysis since 
4d. 
2 treated found dead next day (5 d.) 
* Death due to virus effect established by specific  lesions or virus in CNS (by intracerebral 
passage to 6 to 8 mice) or, as a rule by both; d. refers to day after virus inoculation. 
Experiment  1  (Table III).--Of  twenty-four guinea pigs injected in the  manner 
just described, eight were not treated.  Six of  these died of  virus effect;  the two 
survivors had fever and as will be shown later, developed active immunity. 
Table III shows  that hyperimmnne serum, given 72 or 96 hours after the virus 
inoculation during the manifest encephalitic phase, had no influence on the course 
of the disease.  When the serum was administered 24 hours after the injection of 
virus, three of four animals survived.  The fourth died 18 days after virus inocula- 
tion of characteristic encephalitis.  Of the group receiving the serum 48 hours after 
the virus, one died after the usual incubation period; the other three 9,  13, and 24 
days respectively after virus inoculation. 
The guinea pigs which succumbed after such prolonged incubation periods showed 
no sign of illness until a day or two before death.  The course of the disease was as 
characteristic as that in the control animals which had succumbed 4 or 5 days after 
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were those of acute experimental equine encephalomyelitis (15) with marked degenera- 
tion and necrosis of neurons, characteristic vascular changes and hemorrhages, poly- 
morphonuclear cell invasion, and occasionally  neuronal intranuclear inclusion  bodies. 
In an attempt to prevent the fatal infection in serum-treated animals, occur- 
ring after an extraordinarily prolonged incubation period (hereafter designated 
as "delayed reactions")  another experiment was undertaken.  This time the 
effect of one, two, and three doses of serum was studied. 
Experiment  2  (Chart  /).--One dose of antiserum given 24 to 48 hours after pad 
inoculation of virus failed again to prevent the fatal delayed reaction (cf. Table III). 
On  the other hand,  even when two or three doses of antiserum were administered 
at the indicated intervals  (Chart 1),  one of seven guinea pigs  (No. 9-4) developed 
encephalitic signs and was sacrificed 47 days after inoculation of virus.  The brain 
of this  animal was infectious for mice and  both brain  and  cord  exhibited lesions 
characteristic of experimental equine  encephalomyelitis (cf.  Figs.  1 to 3).  Another 
one (8-9) showed fever on the 20th and 21st days and was sacrificed.  No virus was 
isolated from its brain and histological  study revealed no lesions  indicative of en- 
cephalitis. 
To sum up  the  results  of the  two experiments:  Young guinea pigs which 
received antiserum intracardially 24 to 48 hours following pad inoculation of 
Western virus either survived or developed delayed reactions terminating in 
death.  When the 48-hour dose of antiserum was repeated once or twice, the 
animals survived with one exception.  This guinea pig developed the disease 
after 47 days despite three doses of serum.  Antiserum given 72  or 96 hours 
after the  injection of virus, during  the  encephalitic phase,  was ineffective. 
The conclusions of Traub could thus be confirmed in part.  The main point 
of difference was the frequent  occurrence of delayed reaction in  the present 
series of animals. 
Traub observed in a group of serum-treated guinea pigs one which developed fatal 
encephalitis  on  the  17th  day  after virus  inoculation  and  another  one,  transitory 
myelitis (posterior limb paralysis)  on the  14th day.  The limited number of such 
cases reported may be attributable to the fact that Traub tested all survivors within 
3 weeks for cerebral resistance, and therefore did not observe them over a sufficiently 
long  period  of  time. 
Earlier observations on the  occurrence  of such  delayed reactions should  be re- 
called:  Flexner and Lewis after serotherapy of experimental poliomyelitis in monkeys 
(16) and Green and coworkers after injection of serum-virus mixtures in experimental 
fox encephalitis (17). 
In the following investigations methods were applied which had been used 
previously in the analysis of the quantitative relation between neutralizing anti- 
body and  resistance  in  actively immunized  animals  (7,  18).  The antibody 
titers of sera of the treated and untreated guinea pigs of Experiments 1 and 2 368  RESISTANCE  TO  EQUINE  ENCEPHALOMYELITIS  VIRUS.  II 
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CHART 1.  Experiment  2.  Effect of single and repeated  doses  of  hyperimmune  rabbit  serum 
in guinea pigs inoculated with Western virus (0.125 cc. 20 per cent suspension into each hind pad). 
Dosage of antiserum:  1 cc. undiluted serum intracardially for first injection, intraperitoneally  for 
second and third.  Injection indicated by arrow-head.  Temperatures at  103.6  ° or above are filled 
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were studied to find out (1) whether serum treatment instituted at the speci- 
fied intervals could prevent the production of antibody (active immunization) 
in the guinea pig and  (2)  whether and  to what extent the antibody titers in 
guinea pigs showing delayed reactions differed from the titers in animals which 
survived. 
Neutralizing  Antibody  and Cerebral Resistance in Untreated and Serum-Treated 
Guinea  Pigs 
1.  Neutralizing Antibody in Untreated Guinea Pigs.--We have reported  (18) 
previously that in certain adult rabbits after subcutaneous inoculation of active 
Western virus the virus circulates in the blood for 2 or 3 days.  Mter  its dis- 
appearance from the circulation neutralizing antibody becomes demonstrable in 
the serum.  On the 4th to 6th day the temperature rises to  106-107°F.  and 
at that time virus can be isolated from the brain.  In certain animals permitted 
to run their natural course the temperature drops critically at the time when the 
antibody in the serum reaches a  titer of 1 : 300  (tested with at least 10 M.L.D. 
of virus in mice).  This particular level  was  defined  as  an  indicator  of  the 
adequate supply of antibody to the central nervous system.  It was also found 
(18) that young (4-weeks-old) rabbits, after similar exposure to virus, develop 
typical encephalitis and die before this critical titer of antibody is reached. 
The two surviving control guinea pigs from Experiment 1 were bled on the 25th 
day and No. 7-2 (Experiment 2, Chart 1 and Table IV) was bled on the 14thday after 
virus inoculation.  All three had responded to the virus with fever.  The sera, diluted 
1:300, of all three neutralized at least 10 mouse cerebral lethal doses. 
The reactions of the guinea pig to the inoculated virus patterned themselves 
therefore after those of the rabbit just described. 
2.  Neutralizing  Antibody  in Serum-Treated  Guinea Pigs.--Table  IV  shows 
that,  in contrast to the sera of non-serum-treated guinea pigs which had de- 
veloped active immunity, those of the treated animals failed to reach an anti- 
body titer of  1:300.  Of the sera obtained  12  or  13  days after beginning of 
serum treatment, only a  small number had a  titer of 1:100.  Even after ad- 
ministration  of three doses of antiserum,  the last of which was given only 3 
days prior to bleeding,  the antibody level was no higher. 
The serum of guinea pig 1-11 which had received three doses of antiserum alone 
did reveal a titer of 1:300.  The sera of two other animals in the same group did not, 
however, reach this titer. 
The decrease in antibody content in sera obtained a later period of time pro- 
ceeded at the same rate as that in control guinea pigs (9-8,  1-09,  1-11)  which 
received one, two, and three doses of serum alone. 
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TABLE  IV 
Neutralizing Antibody and Cerebral Resistance Test in Serum-Treated and  Untreated 
Guinea Pigs 
Bled.  Antibody in serum  Test for cerebral resistance  Dosage of  Days 
Guinea  serum and  dilution  Experi-  after 
ment No.  i~io  g.  time after  Outcome  virus 
virus  inocu-  Un. 1:10 1:10  1:300[  Time  Outcome  inoculation  lation  0  interval 
3-0  None:  Survived  25  6 mos.  Survived 
3-5  controls  "  25  6  "  Trauma, died, 
ld. 
1-5  "  25  "4-  6  "  Enceph., died 
1  1-6  1 dose  ,, 
1  d.*  25  6  "  "  " 
1-7  "  25  +  6  "  "  " 
2-0  1 dose  Enceph.,  24 d.  24  + 
2 d.  Sacrificed, 25 d. 
2-2  1 dose  Post-paralysis,  25  +  6  "  Trauma,  died 
3 d.  4 d. Survived  1 d. 
7-2  None:  [ 
i 
control 
Survived.  Acci-  14 
dental death29 
d. 
7-9 
1 dose 
8-2 
ld. 
8-0 
8-3 
1 dose 
8-5 
2d. 
8-6 
2 
7-8 
8-8 
9-1 
3 doses 
9-3  2,  5,  and  " 
lid. 
Enceph.,  14 d.  14  + 
Same as No. 7-9  14  + 
Survived.  Acci-  14  +  ..... 
dental  death 
25 d. 
9-4 
Survived  14 
29  + 
"  14 
29  + 
Enceph.,  pros-  14 
trate 13 d., died 
14 d. 
Survived 
2 doses 
2 and 5 d. 
it 
Enceph.,  47 d. 
+ 
14  -~  .....  10  "  Sick; recoverec 
29  +  --  -- 
14  + 
29  + 
47 
14  +  -Jr  --  10  " 
29  -4-  +  - 
47  +  -- 
14  +  +  -- 
29  -{-  +  -- 
47  + 
14  +  [  +  --  I0  "  Trauma,  died 
29  +  --  1 d. 
10  "  Enceph.,  died 
+  +  --  I0 wks.  Enccph., died 
+  10  "  "  " 
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Experi-  Guinea 
ment No.  ~o. 
1-19 
9-8 
Controls 
(no virus)  1-09 
1-11 
~osage of 
•um and 
me after 
virus 
~culatio~ 
dose 
doses 
d.  inter- 
ral 
doses 
and  6 d. 
intervall 
Outcome 
il~yds  Antibi°~luYt~nSerum  Test for cerebralresistance 
Un. 1:10 l:lO0 1:30-~0  ~  Outcom--------~ 
13  -~"  --  --  7 Wlra.$  Enceph., died 
t+1÷1-/  / 
* 1 d., 2 d., etc., indicates 1, 2, etc. days after virus inoculation. 
~; In the controls the interval after beginning of serum injections is indicated. 
§ In two other animah,  1:300 dilution of serum was negative. 
Table IV also  shows the results of intracerebral  test inoculations  in  certain 
survivors in Experiments 1 and 2. 
All guinea pigs received 0.2 cc. of a 10  -4 dilution of mouse-brain virus suspension. 
In addition two normal, control guinea pigs received 10-4, and two others, 10  "~ vires 
dilution.  All  control animals died of encephalitis.  Of the two non-serum-treated 
survivors (3-0 and 3-6), one died of trauma within a few hours after injection.  The 
other one survived without showing  signs,  even though the test was carried out 6 
months  after  the  immunizing  pad  inoculation.  All  others  showed  characteristic 
signs of encephalomyelitis with fatal outcome in all but one. 
It is clear therefore that the guinea pigs surviving after serotherapy of the 
experimental  infection  did  not  become actively immunized  since  they  suc- 
cumbed to an intracerebral injection of virus, although a  control guinea pig 
receiving virus but no antiserum did resist the test dose.  The results of the 
neutralization and of the resistance tests therefore coincided. 
DISCUSSION 
The present results indicate that in those guinea pigs in which serum therapy 
was effective in suppressing or delaying the onset of the fatal disease the anti- 
genicity of the virus was inhibited.  The interference with or blocking of the 
active antibody production occurred even when serum treatment was begun 
2 days or, in one instance (2-2), 3 days after the inoculation of virus.  Cox and 
Olitsky (19) had already reported for the guinea pig and later Gochenour (20) 
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the active or formalin-inactivated equine encephalomyelitis virus.  Failure of 
serum-treated guinea pigs to resist intracerebral injection of active virus coin- 
cided with failure to develop the high degree of antibody characteristic of active 
immunity.  Similarly Wyck0ff and Tesar (4)  and Traub  (13) found that se- 
rum-treated monkeys or guinea pigs were susceptible to an intracerebral test 
inoculation.  The somewhat irregular findings of Traub in this respect might 
have been due to the fact that he tested guinea pigs after 2 or 3 weeks' observa- 
tion, i.e., at a time when some of them may still have been passively protected 
by the  injected antiserum.  In the present  studies,  no such protection was 
found after 10 weeks. 
Furthermore, neutralization tests, as summarized in Table IV, failed to re- 
veal any consistent difference between sera of guinea pigs which survived the 
time of observation (6 months, Experiment 1; 10 weeks,  Experiment  2)  and 
the  sera  of  those  which  developed  encephalitis  after  prolonged  incubation 
period  (delayed reactions).  Moreover, delayed reaction occurred at  a  time 
when antibody had fallen to a titer of 1 : 10 or lower.  Of special interest is the 
observation that, although the serum of guinea pig 9-4 had an antibody titer 
of 1 : 10 on the 29th day, signs of encephalitis in this animal were not manifest 
until the 47th day, when only undiluted, but not tenfold-diluted serum had a 
neutralizing capacity.  Thus the difference in outcome of serotherapy among 
individual  guinea  pigs  could not be  satisfactorily explained on  the  basis  of 
antibody levels alone. 
Another factor to consider is the persistence of virus in those animals that 
showed delayed reactions.  It is assumed that in those guinea pigs which sur- 
vived the period of observation all virus was effectively neutralized by the anti- 
body injected but that those which developed delayed reactions might have 
harbored virus somewhere out of reach of antibody.  It has been shown by 
Francis (21) for the nasopharyngeal mucosa and by us (7, 18) for the central 
nervous system that the serum antibody titer may be considered as an indi- 
cator in characteristic ratio of the antibody content of tissue fluids.  Thus it 
is conceivable that virus might be held in check when fixed by cells and be re- 
leased to infect other cells as antibody falls to an ineffective level in the sur- 
rounding medium.  The present  investigations did  not  include attempts  to 
determine in which  tissue virus persisted  during the long incubation period 
characterizing delayed reactions.  It is difficult, however, to visualize such per- 
sistence in extraneural tissues since after its release therefrom the virus would 
have had to reach the central nervous system by way of the blood stream but, 
as shown in Table IV, it would then have been exposed to the action of anti- 
body.  It is more likely that a small amount of virus reached the central nerv- 
ous  system  and  there  became fixed, before the antiserum was injected.  It 
may be assumed that the spread of such a  small amount of virus could have 
been arrested by a small amount of antibody in the tissue.  The titer to which 
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that the antibody concentration in the tissue no longer sufficed to hold the virus 
in check. 
In connection with the delayed reactions in serum-treated guinea pigs, the 
case recently reported by Gold and Hampil (22) is of interest:-- 
A laboratory helper was  accidentally infected with Western virus.  On the 6th 
day after exposure he became ill; on the 8th, his serum contained little or no detecta- 
ble antibody.  Repeated antiserum injections were followed by progressive  improve- 
ment until 10 days after the beginning of serum treatment, when he suffered a recur- 
rence of  signs  which  were  diagnosed  as  acute  Parkinsonism  and  subsequently 
recovered with development of a remarkably high titer of antibody. 
The question here is whether a  similar condition prevailed as in the serum- 
treated guinea pigs which manifested delayed reactions. 
SUMMARY  AND  CONCLUSIONS 
Under  none of the  experimental conditions here described was  treatment 
of  the  infection induced  by  the  virus  of Western  equine  encephalomyelitis 
in mice and guinea pigs with specific hyperimmune rabbit serum effective if 
begun after the onset of signs of encephalitis.  In mice,  after  intracerebral 
inoculation of virus, serum was ineffective when given even before that stage. 
After peripheral introduction of virus in guinea pigs the disease was completely 
arrested in certain animals by single or multiple doses of antiserum if treatment 
was begun within 24 to 48 hours after virus inoculation.  In others the incuba- 
tion period was prolonged to 2 or even as long as 7 weeks. 
In  untreated  guinea pigs,  injection of virus alone led  to active immunity 
in those which survived.  Antiserum blocked the antigenicity of active virus 
in the  serum-treated animals.  The decrease in titer in  the sera of all anti- 
serum-treated animals proceeded at the same rate as in those of control guinea 
pigs which  received antiserum  alone.  Thus it  was not  possible  to  predict 
which ones would survive and which would succumb after a  prolonged incuba- 
tion period.  Delayed fatal disease occurred at a  time when the neutralizing 
antibody of the treated guinea pigs  had fallen to a  low titer.  It is therefore 
likely that  the virus which persisted throughout this long  incubation period 
had been prevented from passing to and infecting other cells but reached them 
when antibody fell to an ineffective level in the surrounding medium.  The 
relative frequency of  such  delayed reactions limits  to  a  further extent  the 
degree to which antiserum can be depended on for effective treatment of infec- 
tion with the virus of equine encephalomyelitis. 
BIBLIOGRAPHY 
1.  Rivers,  T.  M.,  Lane  Medical  Lectures, Viruses  and  virus  diseases,  Stanford 
University Publications, University Series, Medical  Sciences, 4, No.  1, Stan- 
ford University Press,  1939, 105-111. 
2.  Rous, P., and Jones, F. S., J. Exp. Med.,  1916, 23~ 601.  Rous, P., McMaster, 
P. D., and Hudack, S. S., J. Exp. Med., 1935, 61~ 657. 374  RESISTANCE  TO EQUINE ENCEPHALOMYELITIS  VIRUS.  II 
3. Zichis, J., and Shaughnessy, H. J., J. Am. Meal. Assn., 1940, 115, 1071. 
3a.  Howitt, B. F., J. Infect. Dis.,  1932, 51~ 493. 
4. Wyckoff, R. W.  G., and Tesar, W. C., .1. Ir~mund.,  1939, 37, 329.  Wyckoff, 
R. W. G., Sdence,  1939, 89, 542. 
5.  Morgan, I. M., and Olitsky, P. K., J. Imrnunol., 1941, 42, 445. 
6.  Morgan, I. M., J. Exp. Meal., 1941, 741 115. 
7.  Morgan, I. M., Schlesinger, R. W., and Olitsky, P. K., J. Exp. Meal., 1942, 76, 
357. 
8. Olitsky, P. K., and Harford, C. G., J. Exp. Me.d,  1938, 68, 173. 
9.  Morgan, I. M., data to be published. 
10.  For description see Jungeblut,  C.  W.,  Seegal, B.  C., and Buchbinder, L., in 
Agents  of disease  and host  resistance,  (F.  P.  Gay, editor), Springfield  and 
Baltimore, Charles  C. Thomas, 1935, 360 ft. 
11.  Freund, J., and Bonanto, M. V., J. Immunol.,  1942, 4~, 71. 
12. Davison, R. O., and Fulton, J. S., quoted by Davison, R. O., Canad. Pub. Health 
J.,  1942, ~  388. 
13. Traub, E., Z~tr. Bakt., 1 Abt., Orig., 1941, 147, 81. 
14.  TenBroeck, C., Hurst, E. W., and Traub, E., J. Exp. Me.d., 1935, 62~ 677.  Hurst, 
E. W., J. Path. and Bact., 1936, 42, 271. 
15.  Sabin, A. B., and Olitsky, P. K., Proc. Sac. Exp. Biol. and Meal., 1938, 68, 595. 
King, L. S., J. Exp. Meal., 1938, 68, 677. 
16.  Flexner, S., and Lewis, P. A., J. Am. Med. Assn., 1910, 55, 662. 
17.  Green, R. G., Ziegler, N. R., Green, B. B., Shillinger, J. E., Dewey, E. T., and 
Carlson, W. E., Am. J. Hyg.,  1935, 21, 366. 
18.  Schlesinger, R. W., Morgan, I. M.,'and Olitsky, P. K., J. Am. Med. Assn., 1942, 
119, 618. 
19.  Cox, H. R., and Olitsky, P. K., J. Exp. Med., 1936, 64, 223. 
20.  Gochenour, W. S., J. Am.  Vet.  Med. Assn., 1939, 95, 374. 
21.  Francis, T., Jr., and Brightman, I. J., Proc. Sac. Exp. Biol. and Med., 1941, 48, 
116.  Francis, T., Jr., Bull. New York Acad. Ivied., 1941, 17~ 268. 
22.  Gold, H., and Hampil, B., Ann. Int. Med., 1942, 16, 556. 
EXPLANATION OF PLATE 20 
Sections fixed in Zenker's-acetic acid solution and stained with eosin and methylene 
blue. 
The photographs were made by Mr. Joseph B. Haulenbeek. 
FIG. I. Anterior horn of upper cervical cord of guinea pig 8-6 (Chart I) which died 
on 14th day after virus inoculation of pads and  12 days after receiving intracardially 
one dose of hyperimmune serum.  To be noted are th~ absence of normally appear- 
ing neurons,  the extensive  necrosis, and the numbers of polymorphonuclear leuco- 
cytes.  X90. 
FIG. 2.  Medulla  of  same  guinea  pig.  Hemorrhages  and  the  vascular  lesions 
characteristic of acute equine  encephalomyelitis  are shown.  ×400. 
FIG. 3.  Hippocampus of same  guinea pig.  A  localized  area  of necrosis  in  the 
layer of large pyramidal ceils; off center to right is a  neuron showing  Nissl  type 
degeneration.  ×400. THE  JOURNAL  OF  EXPERIIV£ENTAL MEDICINE  VOL. 77  PLATE  20 
(Olitsky et al.:  Resistance to equine encephalomyelitis virus.  II) 